Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01257204
What this trial is testing

Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 196
Large-scale testing (Phase 3)Study completedNCT01318694
What this trial is testing

Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants

Who this might be right for
Hepatitis C
Debiopharm International SA 1,081
Not applicableStudy completedNCT03570112
What this trial is testing

Transmission of Chronic Hepatitis C in Pregnancy

Who this might be right for
Hepatitis CPregnancy ComplicationsVertical Disease Transmission
The Christ Hospital 40
Not applicableStudy completedNCT02333292
What this trial is testing

Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions

Who this might be right for
Chronic Hepatitis C Infection
Valme University Hospital 1,128
Post-approval studies (Phase 4)UnknownNCT01731301
What this trial is testing

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

Who this might be right for
Chronic Hepatitis CEnd Stage Renal Disease
Liver Institute of Virginia 20
Testing effectiveness (Phase 2)Study completedNCT00199719
What this trial is testing

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

Who this might be right for
Chronic Hepatitis C
University Hospital, Limoges 30
Large-scale testing (Phase 3)Study completedNCT02251990
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 489
Testing effectiveness (Phase 2)WithdrawnNCT04309734
What this trial is testing

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Who this might be right for
Hepatitis CHepatitis C, ChronicChronic Hepatitis C+2 more
Atea Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Ended earlyNCT00274495
What this trial is testing

Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver

Who this might be right for
Chronic Hepatitis C InfectionFatty Liver
Beth Israel Medical Center 30
Not applicableLooking for participantsNCT00001971
What this trial is testing

Evaluation of Patients With Liver Disease

Who this might be right for
Hepatitis DHepatitis CHepatitis B+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8,050
Not applicableStudy completedNCT00709228
What this trial is testing

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 496
Testing effectiveness (Phase 2)Study completedNCT00880763
What this trial is testing

Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 90
Post-approval studies (Phase 4)Study completedNCT01195181
What this trial is testing

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Who this might be right for
Hepatitis C VirusChronic Liver DiseaseViral Hepatitis+2 more
Azienda Ospedaliera di Padova 506
Post-approval studies (Phase 4)Study completedNCT01684787
What this trial is testing

Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Who this might be right for
Chronic Hepatitis C
Miguel Santin 80
Not applicableStudy completedNCT01416610
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Not applicableStudy completedNCT00596960
What this trial is testing

Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients

Who this might be right for
Alcohol DependenceChronic Hepatitis C
US Department of Veterans Affairs 139
Not applicableStudy completedNCT01200225
What this trial is testing

An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,155
Post-approval studies (Phase 4)WithdrawnNCT03791814
What this trial is testing

A Prospective Cohort Study to Improve HCV Care in Dialysis Patients

Who this might be right for
Hepatitis C
Albert Einstein Healthcare Network
Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Testing effectiveness (Phase 2)Study completedNCT00097435
What this trial is testing

Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Human Genome Sciences Inc. 115
Next Page